Virax Biolabs Group Limited - SIC # 7362 -

Ticker Exchange SIC # Website Latest Ticker
VRAX Nasdaq 7362 viraxbiolabs.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Virax Biolabs Group Limited

Join Virax's Live Investor Webinar: Advancing Immune Diagnostics, Clinical Development and Commercial Execution - Aug 20th, 2026 8:00 am
Virax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV - Aug 7th, 2026 7:00 am
Alliance Entertainment and Virax Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Jul 20th, 2026 7:00 am
Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement - Jul 16th, 2026 5:30 am
Virax Biolabs enters immune profiling product supply deal with Fosun - Jul 13th, 2026 3:48 am
Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds - Jul 10th, 2026 2:05 pm
Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds - Jul 9th, 2026 11:35 am
Why Did Virax Biolabs Stock Triple In One Session? - Jul 9th, 2026 8:31 am
Virax Biolabs Shares Double After Exclusive Fosun Distribution Agreement (VRAX) - Jul 9th, 2026 8:06 am
Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics - Jul 9th, 2026 5:30 am
Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation - Jun 24th, 2026 7:00 am
Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes - May 26th, 2026 5:30 am
Avalon Advanced Materials and Virax Biolabs Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - May 15th, 2026 7:00 am
Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders - Apr 14th, 2026 5:34 am
Virax Biolabs Group Limited (VRAX) Upgraded to Buy: Here's Why - Jan 15th, 2026 10:00 am
Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement - Dec 4th, 2025 2:05 pm
Virax Biolabs Group Limited Announces $5 Million Private Placement - Dec 3rd, 2025 11:53 am
Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders - Dec 3rd, 2025 5:34 am